CSTL
Castle Biosciences, Inc.
NASDAQ · USHealthcareMedical - Diagnostics & Research
$23.89-1.10%
Price as of Jul 20, 2026
CSTL valuation
Castle Biosciences, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.03x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.57x
- Price / sales
- 2.13x
- Price / cash flow
- 15.02x
Enterprise value
- Enterprise value
- $499.8M
- EV / sales
- 1.47x
- EV / EBITDA
- -688.70x
- EV / EBIT
- -15.01x
- Market cap
- $724.7M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.